Enhancement of the epithelial-mesenchymal transition through the activation of the JAK/STAT3 signaling pathway results in increased tumorigenic and metastatic potential, facilitates the transition of cancer stem cells, and contributes to chemoresistance in cancer [16]. The gene discussed is STAT3; the disease is cancer.